Joshua Makower Net Worth

The estimated Net Worth of Joshua Makower is at least $393 Million dollars as of 28 June 2021. Joshua Makower owns over 1,944,444 units of Bright Health stock worth over $392,123,244 and over the last 21 years Joshua sold BHG stock worth over $731,605.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Joshua Makower BHG stock SEC Form 4 insiders trading

Joshua has made over 35 trades of the Bright Health stock since 2016, according to the Form 4 filled with the SEC. Most recently Joshua bought 1,944,444 units of BHG stock worth $34,999,992 on 28 June 2021.

The largest trade Joshua's ever made was buying 9,948,269 units of Bright Health stock on 14 February 2019 worth over $4,675,686. On average, Joshua trades about 1,198,817 units every 42 days since 2003. As of 28 June 2021 Joshua still owns at least 23,983,073 units of Bright Health stock.

You can see the complete history of Joshua Makower stock trades at the bottom of the page.

What's Joshua Makower's mailing address?

Joshua's mailing address filed with the SEC is 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM, MD, 21093.

Insiders trading at Bright Health

Over the last 4 years, insiders at Bright Health have traded over $229,613 worth of Bright Health stock and bought 7,761,026 units worth $110,418,758 . The most active insiders traders include Forest Baskett, Scott D Sandell, and Anthony A. Jr. Florence. On average, Bright Health executives and independent directors trade stock every 25 days with the average trade being worth of $5,149,400. The most recent stock trade was executed by George Lawrence Iii Mikan on 14 December 2023, trading 52,500 units of BHG stock currently worth $858,375.

What does Bright Health do?

Complete history of Joshua Makower stock trades at ARCA biopharma Inc, Ardelyx Inc, AVEO Pharmaceuticals Inc, Genocea Biosciences Inc, IRIDEX, Regulus Therapeutics Inc, Mirum Pharmaceuticals Inc, Trevi Therapeutics, Marker Therapeutics, Akouos, Inozyme Pharma, Metacrine, Eargo, and Bright Health

Bright Health executives and stock owners

Bright Health executives and other stock owners filed with the SEC include:

• George Lawrence Mikan III,
  Vice Chairman, CEO & Pres
• Robert John Sheehy,
  Co-Founder & Exec. Chairman
• Catherine R. Smith,
  Chief Financial & Admin. Officer
• Simeon Schindelman,
  Chief Exec. Officer of Bright HealthCare
• Sanjeev Kumar Srivastava,
  Chief Exec. Officer of NeueHealth
• Keith J. Nelsen,
  Gen. Counsel & Corp. Sec.
• Elizabeth Ross,
  Chief Marketing Officer
• Dr. Tomas David Valdivia M.S.,
  Co-Founder and Chief Health & Equity Officer
• Peter W. Sonsini,
  10% owner
• Mohamad Makhzoumi,
  Director
• Jay Matushak,
  Chief Financial Officer
• Michael A Carson,
  CEO, Bright HealthCare
• Manuel Kadre,
  Director
• Robert J Sheehy,
  Director
• Naomi L Allen,
  Director
• Matthew G Manders,
  Director
• Tomas Valdivia,
  CHIEF HEALTH & EQUITY OFFICER
• Simeon Schindelman,
  CEO, BRIGHT HEALTHCARE
• Scott D Sandell,
  10% owner
• Jeffrey Folick,
  
• Venture Partners Ix L.P.Bes...,
  
• Carmen Chang,
  10% owner
• Sanjeev K Srivastava,
  CEO, NEUEHEALTH
• Cathy R Smith,
  CFO & CAO
• Enterprise Associates 15, L...,
  
• Keith J Nelsen,
  GC & CORPORATE SECRETARY
• Joshua Makower,
  10% owner
• 18 Venture Growth Equity, L...,
  
• George Lawrence Iii Mikan,
  CEO & President
• Forest Baskett,
  10% owner
• Ali Behbahani,
  10% owner
• Anthony A. Jr. Florence,
  10% owner
• Paul Edward Walker,
  10% owner
• Andrew M Slavitt,
  Director
• Linda R Gooden,
  Director
• Adair Newhall,
  Director
• Jeffrey R Immelt,
  Director
• Edward T Mathers,
  10% owner
• Liza Landsman,
  10% owner
• Rick Yang,
  10% owner
• Stephen Kraus,
  Director
• Jeffery Michael Craig,
  GC & Corporate Secretary
• Jeffrey J Scherman,
  Chief Accounting Officer
• Jeffrey S Cook,
  Chief Operating Officer